Sitole, Mugdha <br/><br/>
Telaprevir versus boceprevir in chronic hepatitis C: a meta-analysis of data from phase II and III trials.  [electronic resource] 

 -  Clinical therapeutics  Feb 2013 
 - 190-7 p.  digital 
<br/><br/> Publication Type: Journal Article; Meta-Analysis 
<br/><br/><label>ISSN: </label>1879-114X 
<br/><br/><label>Standard No.: </label>10.1016/j.clinthera.2012.12.017  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Clinical Trials, Phase II as Topic<br/>Clinical Trials, Phase III as Topic<br/>Drug Therapy, Combination<br/>Hepatitis C, Chronic--drug therapy<br/>Humans<br/>Interferon-alpha--therapeutic use<br/>Oligopeptides--administration & dosage<br/>Polyethylene Glycols--therapeutic use<br/>Proline--administration & dosage<br/>Protease Inhibitors--administration & dosage<br/>Randomized Controlled Trials as Topic<br/>Recombinant Proteins--therapeutic use<br/>Ribavirin--therapeutic use